116 related articles for article (PubMed ID: 302157)
1. Effects of the injectable contraceptive depot medroxyprogesterone acetate in Thai women with liver fluke infestation: results after six months.
Grossman RA; Assawasena V; Chalpati S; Taewtong D
Bull World Health Organ; 1977; 55(1):67-78. PubMed ID: 302157
[TBL] [Abstract][Full Text] [Related]
2. Effects of the injectable contraceptive depot medroxyprogesterone acetate in Thai women with liver fluke infestation: final results.
Grossman RA; Asawasena W; Chalpati S; Taewtong D; Tovanabutra S
Bull World Health Organ; 1979; 57(5):829-37. PubMed ID: 161523
[TBL] [Abstract][Full Text] [Related]
3. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
[TBL] [Abstract][Full Text] [Related]
4. Continuation of injectable contraceptives in Thailand.
Narkavonnakit T; Bennett T; Balakrishnan TR
Stud Fam Plann; 1982 Apr; 13(4):99-105. PubMed ID: 6216633
[TBL] [Abstract][Full Text] [Related]
5. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
6. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
Polaneczky M; Guarnaccia M; Alon J; Wiley J
Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.
Pongsatha S; Ekmahachai M; Chaovisitsaree S; Suntornlimsiri N; Morakote N
J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231
[TBL] [Abstract][Full Text] [Related]
8. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
Kaunitz AM
Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
[TBL] [Abstract][Full Text] [Related]
9. Return of ovulation after the cessation of depot-medroxy progesterone acetate treatment in Thai women.
Saxena BN; Dusitsin N; Tankeyoon M; Chaudhury RR
J Med Assoc Thai; 1980 Feb; 63(2):66-9. PubMed ID: 7365344
[TBL] [Abstract][Full Text] [Related]
10. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.
Lizarelli PM; Martins WP; Vieira CS; Soares GM; Franceschini SA; Ferriani RA; Patta MC
Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439
[TBL] [Abstract][Full Text] [Related]
11. Effect of medroxyprogesterone acetate contraception on human serum enzymes.
Mukherjea M; Mukherjee P; Biswas R; Chakraborty AS; Kushari J
Int J Fertil; 1981; 26(1):35-9. PubMed ID: 6113206
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of depot-medroxyprogesterone acetate on lipoprotein metabolism.
Garza-Flores J; De la Cruz DL; Valles de Bourges V; Sanchez-Nuncio R; Martinez M; Fuziwara JL; Pérez-Palacios G
Contraception; 1991 Jul; 44(1):61-71. PubMed ID: 1832626
[TBL] [Abstract][Full Text] [Related]
13. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.
Westhoff C
J Reprod Med; 1996 May; 41(5 Suppl):401-6. PubMed ID: 8725702
[TBL] [Abstract][Full Text] [Related]
14. [Injectable contraceptive, DMPA, serum HDL cholesterol and heart infarct].
Kremer J; de Bruijn HW; Hindriks FR
Ned Tijdschr Geneeskd; 1981 Aug; 125(35):1418-21. PubMed ID: 6456421
[TBL] [Abstract][Full Text] [Related]
15. Metabolic side-effects of injectable depot-medroxyprogesterone acetate, 150 mg three-monthly, in undernourished lactating women. WHO Task Force on Long-acting Agents for Fertility Regulation.
WHO Task Force on Long-acting Agents for Fertility Regulation
Bull World Health Organ; 1986; 64(4):587-94. PubMed ID: 3490928
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of injectable contraceptive users in a low-income population in Texas.
Sangi-Haghpeykar H; Poindexter AN; Moseley DC; Bateman L; Reid ED
Fam Plann Perspect; 1995; 27(5):208-11, 225. PubMed ID: 9104608
[TBL] [Abstract][Full Text] [Related]
17. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of depot medroxyprogesterone acetate contraception.
Mishell DR
J Reprod Med; 1996 May; 41(5 Suppl):381-90. PubMed ID: 8725700
[TBL] [Abstract][Full Text] [Related]
19. Serum high density lipoprotein cholesterol levels in women using a contraceptive injection of depot-medroxyprogesterone acetate.
Kremer J; de Bruijn HW; Hindriks FR
Contraception; 1980 Oct; 22(4):359-67. PubMed ID: 7449384
[TBL] [Abstract][Full Text] [Related]
20. [An introductory clinical trial of three-monthly injectable contraceptive-depot medroxyprogesterone acetate].
Shao Q; Jiang H; Fu W
Zhonghua Fu Chan Ke Za Zhi; 1999 Jan; 34(1):36-9. PubMed ID: 11263172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
